Nadia S. Fairbairn

St. Paul's Hospital
Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder in the Fentanyl Era.

Slow-Release Oral Morphine vs Methadone for Opioid Use Disorder in the Fentanyl Era.

Journal: JAMA network open

Published: March 24, 2026

Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.

Real-world comparative effects of slow-release oral morphine vs. methadone on healthcare use for opioid use disorder: A population-based target trial emulation.

Journal: Addiction (Abingdon, England)

Published: March 16, 2026

Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: A population-based interrupted time series analysis.

Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: A population-based interrupted time series analysis.

Journal: The International journal on drug policy

Published: January 17, 2026

Feasibility and Acceptability of a Pilot Contingency Management Intervention for Stimulant Use Disorder in a Hospital Setting.

Feasibility and Acceptability of a Pilot Contingency Management Intervention for Stimulant Use Disorder in a Hospital Setting.

Journal: Journal of addiction medicine

Published: January 15, 2026

An application of hospital at home for precariously housed people who use drugs in a community-based harm reduction setting in Vancouver, Canada.

An application of hospital at home for precariously housed people who use drugs in a community-based harm reduction setting in Vancouver, Canada.

Journal: Addiction science & clinical practice

Published: December 15, 2025

Safe Supply at Insite, North America's First Supervised Consumption Site: A Case Report of Reduced Harms From the Toxic Drug Supply in a Client Prescribed Powdered Fentanyl Alternative.

Safe Supply at Insite, North America's First Supervised Consumption Site: A Case Report of Reduced Harms From the Toxic Drug Supply in a Client Prescribed Powdered Fentanyl Alternative.

Journal: Drug and alcohol review

Published: December 02, 2025

Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program.

Community Pharmacy-Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program.

Journal: Drug and alcohol review

Published: May 09, 2025

Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.

Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.

Journal: Harm reduction journal

Published: March 26, 2025

Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada.

Comparative Effectiveness of Buprenorphine/Naloxone and Methadone on Methamphetamine/Amphetamine Use Among People with Opioid Use Disorder in Canada.

Journal: Substance use & addiction journal

Published: November 30, 2024

Intravenous Fentanyl for Symptom Management in Hospitalized Patients With Refractory Opioid Withdrawal: A Retrospective Cohort Study.

Intravenous Fentanyl for Symptom Management in Hospitalized Patients With Refractory Opioid Withdrawal: A Retrospective Cohort Study.

Journal: Journal of addiction medicine

Published: November 03, 2024

Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020.

Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020.

Journal: Drug and alcohol dependence

Published: October 13, 2024

Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder.

Redesigning a Stopped Clinical Trial as an Emulated Trial Using Real-World Data to Explore the Effectiveness of Slow-Release Oral Morphine as a Treatment for Opioid Use Disorder.

Journal: Substance use & addiction journal

Published: October 12, 2024

Showing 1-12 of 112

Last Updated: 09/26/2026